Pharmaceuticals

Intuitive Surgical Surpasses Q4 Expectations

Intuitive Surgical's Q4 revenue surged 25%, fueled by strong system placements. Analysts express optimism about future growth.

Bird Flu Risk Sparks Pharma Gains

The recent H5N1 bird flu death and rising seasonal flu cases create investment opportunities in pharmaceuticals and healthcare, highlighting pandemic preparedness.

Promising Results for Amgen's MariTide

Amgen's MariTide shows promising weight-loss results but faces competition and side effect challenges.

Merck Eyes Incyte for Possible Acquisition

Merck (MRK) is rumored to be pursuing Incyte (INCY), prompting market volatility.

Inside the Market Dominance of the Top 10 Pharma Giants

From innovation to influence. The world's biggest pharma players aren't just leaders. They're industry giants. This infographic shows their outsized impact.

Evotec Receives Takeover Bid from Halozyme (HALO)

Evotec has received a takeover offer from Halozyme, potentially creating a major player in life sciences. Retail investors should watch for market impacts.

NTRA Stock: Impressive Growth and Rising Profit Margins

Natera's impressive Q3 2024 highlights its strong position in the genetic testing market.

Global Fungal Outbreaks Surge

Fungal outbreaks are increasing globally, impacting health systems and creating new investment opportunities in antifungal research and treatments.

INGR Stock: Ingredion Targets Growth in Specialty Ingredients Market

Learn how specialty ingredients leader Ingredion is driving growth and targeting new markets in the consumer staples sector.

BMY Breaking New Ground in Schizophrenia Treatment

Bristol Myers Squibb's Cobenfy, the first new schizophrenia treatment in over 70 years, offers hope for patients and investment potential for the market.

Viridian Therapeutics: A Biotech Tapping High-Growth Potential

See how Viridian Therapeutics (NASDAQ: VRDN) is innovating thyroid eye disease treatments with advanced therapies and a growing market opportunity.

Billion-Dollar Market Potential for Targeted Cancer Therapies

Radiopharmaceuticals are revolutionizing cancer treatment, attracting billions in investments. Discover the potential and challenges for investors in this emerging market.

Roche Shares Tumble After Obesity Drug Data

Roche's stock dropped 4.5% due to gastrointestinal side effects from its obesity drug CT-388, raising concerns among investors about the drug's future.

Rising GLP-1 Medication Use to Drive Employer Healthcare Costs

Discover the financial impact of rising GLP-1 medication usage on employer healthcare costs and its relevance for retail investors.

Johnson & Johnson Proposes $6.48 Billion Settlement for Talc Lawsuits

Discover why Johnson & Johnson's $6.48 billion talc settlement matters for retail investors: stock impact, legal risks, governance insights, financial health, and industry precedent.